(NASDAQ:LFMD) PHILADELPHIA, Aug. 28, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through...
Related Questions
How might the class action lawsuit affect LFMD's short‑term price volatility and trading volume?
What is the potential financial exposure or settlement amount, and how could it impact the company's balance sheet?
Are there any precedents with similar biotech/health‑tech firms where lawsuits caused lasting effects on valuation or credit facilities?